Slow fusion pore expansion creates a unique reaction chamber for co-packaged tPA and PAI.
dc.contributor.author | Bohannon, KP | |
dc.contributor.author | Bittner, MA | |
dc.contributor.author | Lawrence, DA | |
dc.contributor.author | Axelrod, D | |
dc.contributor.author | Holz, RW | |
dc.coverage.spatial | Ann Arbor, MI | |
dc.date.accessioned | 2024-09-27T15:51:36Z | |
dc.date.available | 2024-09-27T15:51:36Z | |
dc.date.issued | 2018-04-01 | |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pubmed/28882880 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/195095 | en |
dc.description.abstract | A lumenal secretory granule protein, tissue plasminogen activator (tPA), greatly slows fusion pore dilation and thereby slows its own discharge. We investigated another outcome of the long-lived narrow fusion pore: the creation of a nanoscale chemical reaction chamber for granule contents in which the pH is suddenly neutralized upon fusion. Bovine adrenal chromaffin cells endogenously express both tPA and its primary protein inhibitor, plasminogen activator inhibitor 1 (PAI). We found by immunocytochemistry that tPA and PAI are co-packaged in the same secretory granule. It is known that PAI irreversibly and covalently inactivates tPA at neutral pH. We demonstrate with zymography that the acidic granule lumen protects tPA from inactivation by PAI. Immunocytochemistry, total internal reflection fluorescence (TIRF) microscopy, and polarized TIRF microscopy demonstrated that co-packaged PAI and tPA remain together in granules for many seconds in the nanoscale reaction chamber, more than enough time to inhibit tPA and create a new secreted protein species. | |
dc.description.sponsorship | Frontiers in Cardiovascular Science Seminar Series. Frankel Cardiovascular Center, University of Michigan. | |
dc.language | eng | |
dc.subject | Animals | |
dc.subject | Cattle | |
dc.subject | Cell Membrane | |
dc.subject | Cells, Cultured | |
dc.subject | Chromaffin Cells | |
dc.subject | Humans | |
dc.subject | Hydrogen-Ion Concentration | |
dc.subject | Membrane Fusion | |
dc.subject | Plasminogen Activator Inhibitor 1 | |
dc.subject | Protein Binding | |
dc.subject | Secretory Vesicles | |
dc.subject | Tissue Plasminogen Activator | |
dc.title | Slow fusion pore expansion creates a unique reaction chamber for co-packaged tPA and PAI. | |
dc.type | Presentation | |
dc.identifier.pmid | 28882880 | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/195095/2/Slow fusion pore expansion creates a unique reaction chamber for co-packaged cargo.pdf | |
dc.identifier.doi | 10.1085/jgp.201711842 | |
dc.identifier.doi | https://dx.doi.org/10.7302/24334 | |
dc.date.updated | 2024-09-27T15:51:33Z | |
dc.identifier.orcid | 0000-0002-2097-8183 | |
dc.identifier.orcid | 0000-0003-3126-1935 | |
dc.identifier.orcid | 0000-0002-6945-7805 | |
dc.identifier.name-orcid | Bohannon, KP; 0000-0002-2097-8183 | |
dc.identifier.name-orcid | Bittner, MA | |
dc.identifier.name-orcid | Lawrence, DA; 0000-0003-3126-1935 | |
dc.identifier.name-orcid | Axelrod, D | |
dc.identifier.name-orcid | Holz, RW; 0000-0002-6945-7805 | |
dc.working.doi | 10.7302/24334 | en |
dc.owningcollname | Pharmacology, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.